Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CULLETTA, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.146
EU - Europa 1.758
AS - Asia 1.285
Continente sconosciuto - Info sul continente non disponibili 307
SA - Sud America 235
AF - Africa 38
OC - Oceania 14
Totale 5.783
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.065
IT - Italia 728
RU - Federazione Russa 441
SG - Singapore 388
CN - Cina 281
BR - Brasile 169
VN - Vietnam 125
HK - Hong Kong 120
FR - Francia 95
PL - Polonia 89
DE - Germania 84
BD - Bangladesh 77
GB - Regno Unito 67
JP - Giappone 61
IN - India 55
FI - Finlandia 51
CA - Canada 41
KR - Corea 29
NL - Olanda 29
ES - Italia 28
AT - Austria 27
TR - Turchia 26
AR - Argentina 25
CH - Svizzera 22
BE - Belgio 20
MX - Messico 20
IL - Israele 18
IE - Irlanda 17
IQ - Iraq 16
SA - Arabia Saudita 15
AU - Australia 14
IR - Iran 14
RO - Romania 14
SE - Svezia 14
PK - Pakistan 13
UA - Ucraina 12
CO - Colombia 11
PT - Portogallo 10
EC - Ecuador 7
ID - Indonesia 7
PY - Paraguay 7
VE - Venezuela 7
ZA - Sudafrica 7
JM - Giamaica 6
UZ - Uzbekistan 6
XK - ???statistics.table.value.countryCode.XK??? 6
MY - Malesia 5
CI - Costa d'Avorio 4
CL - Cile 4
DZ - Algeria 4
EG - Egitto 4
MA - Marocco 4
NG - Nigeria 4
TW - Taiwan 4
CZ - Repubblica Ceca 3
KE - Kenya 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
NP - Nepal 2
PE - Perù 2
SC - Seychelles 2
TH - Thailandia 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GL - Groenlandia 1
HN - Honduras 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
NI - Nicaragua 1
PR - Porto Rico 1
QA - Qatar 1
SL - Sierra Leone 1
SN - Senegal 1
TN - Tunisia 1
UY - Uruguay 1
Totale 5.483
Salva come PNG Salva come JPEG
Città #
San Jose 286
Ashburn 284
Singapore 265
Palermo 245
Hong Kong 101
Chandler 100
New York 74
Moscow 73
Council Bluffs 71
Zgierz 70
Los Angeles 68
Rome 56
Ho Chi Minh City 51
Ann Arbor 49
Fairfield 49
Helsinki 43
Beijing 42
Tokyo 37
Hefei 32
Lauterbourg 31
Milan 30
Dallas 29
The Dalles 28
Seattle 27
Wilmington 27
Hanoi 26
Santa Clara 23
Boardman 22
Partanna 22
Corciano 21
Woodbridge 21
Buffalo 20
Chicago 19
Dublin 18
Medford 18
Perugia 18
Houston 17
São Paulo 17
Cincinnati 16
Frankfurt am Main 15
London 15
Philadelphia 15
Cefalù 14
Phoenix 14
Tel Aviv 14
Washington 14
Des Moines 13
Toronto 13
Atlanta 12
Hyderabad 12
Naples 12
Princeton 12
San Diego 12
Vienna 12
Barcelona 11
Catania 11
Messina 11
Orem 11
Brussels 10
Chennai 10
Nuremberg 10
Warsaw 10
Birmingham 9
Brooklyn 9
Lawrence 9
Ludwigshafen am Rhein 9
Mexico City 9
Montreal 9
Stockholm 9
Baton Rouge 8
Cambridge 8
Riyadh 8
Brest 7
Columbus 7
Da Nang 7
Lafayette 7
Madrid 7
Nanjing 7
Napoli 7
Osaka 7
Redwood City 7
Biên Hòa 6
Brasília 6
Cleveland 6
Denver 6
Guangzhou 6
Hoover 6
Istanbul 6
Lappeenranta 6
Mumbai 6
Rio de Janeiro 6
Shanghai 6
Sydney 6
Vittoria 6
Altamura 5
Amadora 5
Basel 5
Belo Horizonte 5
Bexley 5
Jeddah 5
Totale 2.987
Salva come PNG Salva come JPEG
Nome #
A comprehensive computational analysis of NR2F2/6 receptors for drug repurposing 276
Indicaxanthin, a multi-target natural compound from Opuntia ficus-indica fruit: From its poly-pharmacological effects to biochemical mechanisms and molecular modelling studies 257
Uno studio comparativo in silico sui possibili target di Ataluren e analoghi farmaci promotori di readthrough di codoni di stop prematuri 244
Pharmacophore-Based Design of New Chemical Scaffolds as Translational Readthrough-Inducing Drugs (TRIDs) 228
FTSJ1 INHIBITION AS A STRATEGY FOR NONSENSE MUTATION SUPPRESSION IN TP53: INTEGRATIVE COMPUTATIONAL AND EXPERIMENTAL ANALYSIS 216
NEW TRANSLATIONAL READTHROUGH INDUCING DRUGS RESCUING NONSENSE MUTATED TP53: STRATEGIES AGAINST CANCER 204
Exploring the SARS-CoV-2 proteome in the search of potential inhibitors via structure-based pharmacophore modeling/docking approach 203
Potential translational readthough inducin drugs: an optimized design and synthesis of new chemical scaffolds 189
Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis 187
A definitive pharmacophore modelling study on CDK2 ATP pocket binders: Tracing the path of new virtual high-throughput screenings 187
INVESTIGATING THE NR2F2 STRUCTURE FOR DRUG REPURPOSING 186
Investigating the inhibition of FTSJ1 a tryptophan tRNA-specific 2’-O-methyltransferase by NV TRIDs, as a mechanism of readthrough in nonsense mutated CFTR 176
Design of small molecules and identification of putative anticancer therapeutic targets via in silico tools 172
RESCUING P53 BY NEW TRANSLATIONAL READTHROUGH INDUCING DRUGS 169
CHA on CDK2: a way to identify the best pharmacophore model for the virtual screening of new inhibitors 159
Aminoquinolines: Fluorescent sensors to DNA – A minor groove probe. Experimental and in silico studies 153
Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects 144
Comparing molecular dynamics-derived pharmacophore models with docking: A study on CDK-2 inhibitors 140
Evaluation of the IKKβ Binding of Indicaxanthin by Induced-Fit Docking, Binding Pose Metadynamics, and Molecular Dynamics 140
Sulfonamide moiety as "molecular chimera" in the design of new drugs 136
TOWARD ENRICHED VHTS FOR CDK2 INHIBITORS: MOLECULAR DYNAMICS, PHARMACOPHORE MODELLING, AND DOCKING 133
Missense mutations in MMACHC protein from cblC disease affect its conformational stability and vitamin B12-binding activity: The example of R161Q mutation 131
Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods 131
Exploring the non-covalent ligand-binding mechanism on immunoproteasome by enhanced Molecular Dynamics 131
In Silico Design, Synthesis and Biological Evaluation of Anticancer Arylsulfonamide Endowed with Anti-Telomerase Activity 121
Beyond Nonsense: New Molecules as Precision Therapy for Rare Genetic Diseases 120
Exploring the new non-covalent immunoproteasome inhibitors of β1i /β5i subunits: Virtual screening and in vitro test 120
In silico-guided exploration of SIRT6 modulation: Discovery of new fragments hits inhibitors 112
Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors 104
CDK2 Allosteric Modulators: The New Route in the Design of New Drugs as Anticancer and Non-hormonal Contraceptives 88
Biophysical insights into the pathogenicity of rare genetic disease-associated proteins 85
Treatment of Complex Regional Pain Syndrome (Crps): New Perspectives in the Use of Sulfonamides as Modulators of P2x Receptors 85
Development of iRhom2/ADAM17 inhibitors for the treatment of inflammatory diseases. 81
Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome 81
Unveiling Novel Hybrids Quinazoline/Phenylsulfonylfuroxan Derivatives with Potent Multi-Anticancer Inhibition: DFT and In Silico Approach Combining 2D-QSAR, Molecular Docking, Dynamics Simulations, and ADMET Properties 80
Non-covalent immunoproteasome inhibitors: virtual screening and in vitro test on β1i /β5i subunits 79
Design, Synthesis, Characterization, in Vitro Biological Evaluation, and in Silico Investigation of 4-Substituted Arylidene Pyrazolones Through Docking, Molecular Dynamics Simulations, and DFT Studies 78
Targeting R-Loop–Driven Replicative Stress in Fanconi Anemia– Deficient Tumors 57
Docking in the Dark: Insights into Protein–Protein and Protein–Ligand Blind Docking 57
QSAR-Guided Design of Serotonin Transporter Inhibitors Supported by Molecular Docking and Biased Molecular Dynamics 36
Development of a proteomic framework for sheddome-wide assessment of iRhom2 inhibitors 33
NR2F2 and NR2F6 as targets for drug repurposing: an insight by means of computational analysis 21
Repurposing of lansoprazole and nitazoxanide as NR2F2 inhibitors in the gastric cancer cell line GCIY: computational insights and siRNA-mediated in vitro tests 19
Rescuing TP53 from nonsense: novel triazoles for translational readthrough via optimized drug design 17
Combined In Silico Approaches for Virtual Screening of Noncovalent Immunoproteasome Inhibitors for Multiple Myeloma Treatment 17
Totale 5.783
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.965
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022137 0 0 0 9 1 7 19 12 16 21 16 36
2022/2023351 30 38 9 29 63 55 22 25 28 5 20 27
2023/2024264 29 19 17 8 15 52 21 8 2 27 25 41
2024/20251.006 21 24 37 97 41 84 70 121 76 117 96 222
2025/20262.754 173 61 205 336 263 394 366 270 189 174 148 175
2026/2027854 154 94 509 97 0 0 0 0 0 0 0 0
Totale 5.783